Cardiol Therapeutics (NASDAQ:CRDL) Earns “Buy” Rating from HC Wainwright
Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $9.00 price target on the stock. Several other research firms have also commented on CRDL. RODMAN&RENSHAW raised shares of […]
Cardiol Therapeutics (NASDAQ:CRDL – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities research analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $9.00 price target on the stock. Several other research firms have also commented on CRDL. RODMAN&RENSHAW raised shares of […]
